Clinical Trials Directory

Trials / Completed

CompletedNCT02937389

Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After Esophagectomy

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Nagasaki University · Academic / Other
Sex
All
Age
20 Years – 84 Years
Healthy volunteers
Not accepted

Summary

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Detailed description

The development and improvement of thoracoscopic esophagectomy (TE) reduced the severe pulmonary complication after esophagectomy. However, the postoperative complications relative to gastric conduit reconstruction are still common issues after esophagectomy. The ischemia of the proximal portion of the graft predisposes these patients to a high incidence of anastomotic complications after esophagectomy. Less commonly, severe graft ischemia can lead to transmural necrosis. Thus, early diagnosis of ischemic reaction may provide the suitable postoperative management and therapeutic intervention to prevent leakage, strictures and necrosis. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPatients after esophagectomyEndoscopic examinations are performed at 1 and 8 postoperative days. Endoscopic examination is added when abnormal findings are demonstrated.

Timeline

Start date
2015-05-01
Primary completion
2018-11-01
Completion
2019-11-01
First posted
2016-10-18
Last updated
2023-04-05

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02937389. Inclusion in this directory is not an endorsement.